Research by a Rutgers ecologist shows biodiversity improves physical and mental health, but warns of some potential risks.

The third annual Fall Sustainability Conference addressed issues ranging from food insecurity to the environmental impacts of artificial intelligence.

Rutgers Office for Research celebrated and honored the 2025 Rutgers Innovation Awards recipients at the RIA ceremony.

Rutgers researchers urge protection of the infrastructure that keeps communities safe.

To reduce claim denials and ensure providers are compensated, hospitals and clinics should ensure their software is compatible, according to a Rutgers researcher.

Rutgers-Camden faculty artist Stass Shpanin, who embraces history in ways that challenge myth and ideology, presented a solo exhibition, Forbidden Garden, at the PLATO gallery on New York’s Lower East Side, and concurrently, has been featured in the Delaware Contemporary Art+AI Biennial exhibition, which explores the theme of artificial intelligence (AI) in the arts.

A study published in the July 2024 issue of Rutgers University’s Journal of Studies on Alcohol and Drugs overturned decades of conventional wisdom: No level of alcohol consumption is safe. The news ricocheted across newspapers, blogs and policy papers worldwide. Overnight, drinkers paused, putting down their glasses to ponder the health implications of their habit.

“It is by far our most downloaded article ever,” said Paul Candon, the journal’s editorial director. “The impact and reach in the field are off the charts.”

An inaugural pilot grant program at Rutgers Health supports the use of data resources to further health care and population health studies.

The Office for Research at Rutgers, The State University of New Jersey, has released its Rutgers Research and Innovation Annual Impact Report for Fiscal Year 2025.

Physicist Lucien Dupuy–whose work has captured international recognition--was one of six finalists to receive a Blavatnik Regional Award for Young Scientists, which honors outstanding postdoctoral scientists from research institutions across New York, New Jersey and Connecticut.

Batten Disease – neuronal ceroid lipofuscinoses (NCLs) – is a group of rare and fatal neurogenerative genetic disorders in young children whose symptoms were untreatable until Robert Wood Johnson Medical School and the Rutgers Center for Advanced Biotechnology and Medicine researchers Peter Lobel and David Sleat discovered the disease’s genetic cause in 1997. Their groundbreaking discovery and partnership with the Office for Research (OfR) Technology Transfer team and biopharmaceutical company BioMarin led to Brineura, the first life-extending treatment for young patients.

Steg.AI, a startup, was founded by double Rutgers graduate Eric Wengrowski and School of Engineering professor Kristin Dana, PhD. The company is based on information security software technology that was developed at Rutgers called light field messaging, which according to Wengrowski is “an advanced forensic water marking technique that adds information to files like images, video, PDFs, GIFs, etc., that is invisible to [people] but visible to [Steg.AI’s] algorithms or even a camera. This information is essentially embedded into these files as forensic tracers."